CKD Bio Corp. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported negative sales was KRW 0.00011 million compared to sales of KRW 0.00035 million a year ago. Net loss was KRW 4,259.98 million compared to net income of KRW 1,358.35 million a year ago. Basic loss per share from continuing operations was KRW 777 compared to basic earnings per share from continuing operations of KRW 252 a year ago. Basic loss per share was KRW 777 compared to basic earnings per share of KRW 252 a year ago. For the nine months, negative sales was KRW 0.00012 million compared to KRW 0.00072 million a year ago. Net loss was KRW 5,742.85 million compared to net income of KRW 7,194.32 million a year ago. Basic loss per share from continuing operations was KRW 1,047 compared to basic earnings per share from continuing operations of KRW 1,336 a year ago. Basic loss per share was KRW 1,047 compared to basic earnings per share of KRW 1,336 a year ago.